Kouidmi Imène, Levesque Roger C, Paradis-Bleau Catherine
Department of Microbiology, Infectiology and Immunology, Université de Montreal, Montreal, Quebec, Canada.
Mol Microbiol. 2014 Oct;94(2):242-53. doi: 10.1111/mmi.12758. Epub 2014 Sep 5.
With antibiotic resistance mechanisms increasing in diversity and spreading among bacterial pathogens, the development of new classes of antibacterial agents against judiciously chosen targets is a high-priority task. The biochemical pathway for peptidoglycan biosynthesis is one of the best sources of antibacterial targets. Within this pathway are the Mur ligases, described in this review as highly suitable targets for the development of new classes of antibacterial agents. The amide ligases MurC, MurD, MurE and MurF function with the same catalytic mechanism and share conserved amino acid regions and structural features that can conceivably be exploited for the design of inhibitors that simultaneously target more than one enzyme. This would provide multi-target antibacterial weapons with minimized likelihood of target-mediated resistance development.
随着抗生素耐药机制的多样性不断增加并在细菌病原体中传播,开发针对经过审慎选择的靶点的新型抗菌剂成为一项高度优先的任务。肽聚糖生物合成的生化途径是抗菌靶点的最佳来源之一。在这条途径中存在Mur连接酶,在本综述中被描述为开发新型抗菌剂的高度合适的靶点。酰胺连接酶MurC、MurD、MurE和MurF具有相同的催化机制,并共享保守的氨基酸区域和结构特征,理论上可用于设计同时靶向多种酶的抑制剂。这将提供多靶点抗菌武器,使靶点介导的耐药性发展的可能性降至最低。